7/25/2019 Expo Marcadires Tumorales (2)
1/23
UNIVERSIDAD NACIONAL DE CHIMBORAZO
FALCULTAD DE CIENCIAS DE LA SALUD
ESCUELA DE LABORATORIO CLNICO E
HISTOPATOLGICO
CATEDRA DE:
TCNICAS HISTOLGICAS
DOCENTE:
LIC. IVN PEAFIEL
GRUPO: N3 DE RECUPERACION
TERCER SEMESTRE
PERIODO ACADMICO: OCTUBRE 2015- FEBRERO 2016
RIOBAMBA ECUADOR
GRUPO N-3 de e!"#e$!%&'
7/25/2019 Expo Marcadires Tumorales (2)
2/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
INTEGRANTES:
N- APELLIDOS * NOMBRES+ Are!"#$ %&''e(")e, *$r+,)e I)$ N$+$(/ V""$)$3 Ne *&re34) A)$ L!"$ R$,re P$rr$(e' !r(e)7" Br"88"+e
TEMA:
P"e.$/ de 0$!$d1e/ 2"01$e/ 24!'%!$/ 5%/21&6%!$/
PARTICIPACINN9- 25: 50: ;5: 100: O$er ($")e'+"8$"4)
2 100: N& >!
7/25/2019 Expo Marcadires Tumorales (2)
3/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
)er. E'+&' $r$7&re' 'e #!e7e) e)&)+r$r e) 7"er'&' '"+"&' 7e )!e'+r&
&r8$)"'&. A(8!)&' 'e e)!e)+r$) e) ($ &r")$ ! &+r&' @(!"7&' &r#&r$(e'. O+r&' e) (&'
+!&re' / &+r&' +e3"7&'. A ee' '&) #r&7!+&' 7e ($' "'$' (!($' $)er&'$' &
'&) #r&7!"7&' #&r e( !er#& e) re'#!e'+$ $( )er.
L&' $r$7&re' +!&r$(e' '&) !)$ 'er"e 7e '!'+$)"$' !e #!e7e) 7e+e+$r'e
7e#e)7"e)7& 7e( +"#& 7e $r$7&r e) '$)8re &r")$ >ee' ! &+r&' +e3"7&' 7e(
&r8$)"'& / !/$ #re'e)"$ e) !)$ &)e)+r$"4) '!#er"&r $ 7e+er")$7& )"e( #!e7e
")7"$r ($ e"'+e)"$ 7e !) )er.
Se 7e
7/25/2019 Expo Marcadires Tumorales (2)
4/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
OBETIVO GENERAL
C&)&er (&' 7"@ere)+e' $r$7&re' +!&r$(e' / $'&"$r(&' &) ($ +e#r$)$ 7e+e"4)
e) !)$ #er'&)$ &) )er $ +r$' 7e !)$ re"'"4)
7/25/2019 Expo Marcadires Tumorales (2)
5/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
L&' $r$7&re' +!&r$(e' '&) !)$ 'er"e 7e '!'+$)"$' !e #!e7e) 7e+e+$r'e
7e#e)7"e)7& 7e( +"#& 7e $r$7&r e) '$)8re &r")$ >ee' ! &+r&' +e3"7&' 7e(
&r8$)"'& / !/$ #re'e)"$ e) !)$ &)e)+r$"4) '!#er"&r $ 7e+er")$7& )"e( #!e7e
")7"$r ($ e"'+e)"$ 7e !) )er. A!)!e !)$ &)e)+r$"4) $)&r$( 7e !) $r$7&r+!&r$( #!e7$ '!8er"r ($ #re'e)"$ 7e )er e'+& #&r ', "'& )& e' '!@""e)+e #$r$
7"$8)&'+"$r(&. Ge)er$(e)+e '! !+"("7$7 'e re7!e $ '&'#e>$r e( 7"$8)4'+"& &
$(&r$r ($ e&(!"4) 7e !) +!&r 7e+e+$7& #&r &+r&' #r&e7""e)+&'. L$ $/&r #$r+e
7e (&' $r$7&re' +!&r$(e' #!e7e) 'er #r&7!"7&' +$
7/25/2019 Expo Marcadires Tumorales (2)
6/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
?. S! &)e)+r$"4) e) '$)8re ! &+r&' @(!"7&' &r#&r$(e' 7e @"( $e'& 7e
)& !#(e) (&' re!"'"+&' 7e !) $r$7&r +!&r$( "7e$( ")(!'& !>&' 7e e((&' 'e
e) $(+er$7&' e) #r&e'&'
7/25/2019 Expo Marcadires Tumorales (2)
7/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
MARCADORES TUMORALES CON SENSIBILIDAD VARIABLE * BAA
ESPECIFICACIDAD: S&) $!e((&' !/$ 'e)'"$'+$ '! ($'"@"$"4) ($ $)+er"&r >$,$ re@ere)"$ && >e&' 7">& $
($ 'e)'""7r$+$7&' JCA 15. CA 1Q.Q CA 125 CA ;2.? CFRA
21.1K / $)+,8e)& #r&'++"& e'#e,@"& JPSAK.
ENZIMAS: C&& ($ NSE Je)&($'$ )e!r&)$( e'#e,@"$K / L=H J(+"&
7e'>"7r&8e)$'$K.
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 7
7/25/2019 Expo Marcadires Tumorales (2)
8/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
OTROS MARCADORES:A)+"!er#&' @re)+e $ &)r&+e,)$' J#5K #r&+e,)$'
'r"$' J-2 "r&8(&,8$7&/ +!&re' 7e (!($' 8er")$+"$'
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ $/!7$r $ 7"$8)&'+"$r)er 7e >,8$7& / "8"($r($
re$"4) $( +r$+$"e)+& #$r$ e$(!$r e( e'+$7"& e(#r&)4'+"&/ ($ re$"4) $(
+r$+$"e)+& 7e +!&re' 7e (!($' 8er")$+"$'
A)("'"' 7e !+$"4)7e(8e)EGFR
T"#& 7e )erC)er 7e #!(4) 7e (!($' )& #e!e$'
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ $/!7$r $ 7e+er")$r e( +r$+$"e)+& / e( #r&)4'+"&
A)("'"' 7e !+$"4) 7e( 8e) KRAS
T"#&' 7e )er C)er &(&rre+$(/ )er 7e #!(4) 7e (!($' )&
#e!e$'
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 8
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000658873&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045695&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270735&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045849&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046063&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000658873&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045695&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270735&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045849&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046063&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanish7/25/2019 Expo Marcadires Tumorales (2)
9/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) !) +"#& e'#e,@"&
7e +er$#"$ 7"r"8"7$e' $#r"$7&
A)+,8e)& $r")&e$ re8re'$7&
A)+,8e)& #r&'++"& e'#e,@"&JPSAK
T"#& 7e )erC)er 7e #r4'+$+$
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& e$(!$r ($ re$"4) $( +r$+$"e)+&
/
CA15-CA2;.2Q
T"#& 7e )er C)er 7e 'e)&
Te3"7& $)$("$7& S$)8re
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 9
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000357558&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046540&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045861&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737144&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044998&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000357558&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046540&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045861&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737144&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044998&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanish7/25/2019 Expo Marcadires Tumorales (2)
10/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
C4& 'e !'4 P$r$ e$(!$r '" e( +r$+$"e)+& e'+ @!)"&)$)7& & '" ($
e)@ere7$7 >$ re8re'$7&
CA1Q-Q
T"#&' 7e )erC)er 7e #)re$' )er 7e e',!($
7/25/2019 Expo Marcadires Tumorales (2)
11/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) !)$ +er$#"$ 7"r"8"7$ e' e(
$7e!$7&
C(!($' +!&r$(e' "r!($)+e' 7e &r"8e) e#"+e("$(JCELLSEARCHK
T"#&' 7e )er C)ere' e+$'++"&' 7e 'e)& 7e#r4'+$+$/ &(&rre+$(
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ 7$r @&r$ $ ($ +&$ 7e 7e"'"&)e' 7"$' / #$r$ e$(!$r
e( #r&)4'+"&
Cr&&8r$)")$ AJC8AK
T"#& 7e )erT!&re' )e!r&e)7&r")&'
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& e) ($ e$(!$"4) 7e ($ re$"4) $(
+r$+$"e)+& / e) ($ e$(!$"4) 7e ($ re"7"$
Cr&&'&$' ; 1; / Q#21
T"#& 7e )erC)er 7e e3"8$
Te3"7& $)$("$7& Or")$
C4& 'e !'4 P$r$ $/!7$r e) ($ "8"($)"$7e re!rre)"$ Jre"7"$K 7e
+!&re'
E)&($'$ )e!r&)$( e'#e,@"$ JNSEK
T"#&' 7e )er C)er 7e #!(4) 7e (!($' #e!e$'/)e!r&
7/25/2019 Expo Marcadires Tumorales (2)
12/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& / e$(!$r ($ re'#!e'+$ $(
+r$+$"e)+&
F"
7/25/2019 Expo Marcadires Tumorales (2)
13/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
G&)$7&+r")$ &r"4)"$ >!$)$ WJBe+$->CGK
T"#&' 7e )er C&r"&$r")&$/ +!&re' 7e (!($' 8er")$+"$'
Te3"7& $)$("$7& Or")$ & '$)8re
C4& 'e !'4 P$r$ e$(!$r e( e'+$7"& e( #r&)4'+"& / ($ re$"4) $(
+r$+$"e)+&
HE?
T"#& 7e )erC)er 7e &$r"&
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ #($)"@"$r e( +r$+$"e)+& 7e( )er e$(!$r e( $$)e 7e ($
e)@ere7$7 / "8"($r ($ re!rre)"$ Jre"7"$K
HER2)e!$#("@"$"4) 7e( 8e) & '&
Te3"7& $)$("$7& S$)8re / &r")$
C4& 'e !'4 P$r$ $/!7$r $ 7"$8)&'+"$r ($ e)@ere7$7 e$(!$r ($ re$"4) $(
+r$+$"e)+& /
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000354453&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046753&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737142&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044945&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046216&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045793&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000354453&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046753&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737142&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044945&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046216&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045793&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanish7/25/2019 Expo Marcadires Tumorales (2)
14/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
L$+$+& 7e'>"7r&8e)$'$
T"#& 7e )er T!&re' 7e (!($' 8er")$+"$'
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ e$(!$r e( e'+$7"& e( #r&)4'+"& / ($ re$"4) $(
+r$+$"e)+&
L"8$)7& 1 7e !er+e #r&8r$$7$ JP=-L1K
T"#& 7e )er C)er 7e #!(4) 7e (!($' )& #e!e$'
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ 7e+er")$r '" e' $#r"$7& e( +r$+$"e)+& &) !) +"#&
#$r+"!($r 7e +er$#"$ 7"r"8"7$
*"r&8(&
T"#&' 7e )er *e($)&$!+)e&/ )er &(&rre+$(
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ 'e(e"&)$r $ #$"e)+e' ' #r&
7/25/2019 Expo Marcadires Tumorales (2)
15/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
*!+$"&)e' 7e (&' 8e)e'BRCA1/ BRCA2
T"#& 7e )er C)er 7e &$r"&
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ 7e+er")$r '" e' $#r"$7& e( +r$+$"e)+& &) !) +"#&
#$r+"!($r 7e +er$#"$ 7"r"8"7$
Pr&+e,)$ 7e $+r" )!(e$r 22 JN*P22K
T"#& 7e )er C)er 7e e3"8$
Te3"7& $)$("$7& Or")$
C4& 'e !'4 P$r$ "8"($r ($ re$"4) $( +r$+$"e)+&
Ree#+&r 7e e'+r48e)&JERK / ree#+&r 7e#r&8e'+er&)$JPRK
T"#& 7e )er C)er 7e 'e)&
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) +er$#"$ >&r&)$(/
$(8!)$' +er$#"$' 7"r"8"7$' e' $#r"$7&
Se((& 7e 5#r&+e,)$'JO$1K
T"#& 7e )er C)er 7e &$r"&'
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ e$(!$r ($ $'$ #("$ $)+e' 7e er$"4) #$r$ (& !e 'e
'&'#e>$ 'er )er 7e &$r"&
Se((& 7e 21 8e)e' JO)&+/#e =ZK
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 15
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046047&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737140&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046409&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045158&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046367&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046047&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737140&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046409&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045158&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046367&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanish7/25/2019 Expo Marcadires Tumorales (2)
16/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
T"#& 7e )er C)er 7e 'e)&
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ e$(!$r e( r"e'8& 7e re!rre)"$ Jre"7"$K
Se((& 7e ;0 8e)e' J*$$#r")+K
T"#& 7e )er C)er 7e 'e)&
Te3"7& $)$("$7& T!&r
C4& 'e !'4 P$r$ e$(!$r e( r"e'8& 7e re!rre)"$ Jre"7"$K
T"r&8(&e#$+"+"' "r$(e' "rr&'"' >e#+"$
e)@ere7$7 ")@($$+&r"$ ")+e'+")$( #&("#&'"'.
CEA
T"#& 7e )er C)er &(&rre+$( 7e e'+4$8& #!(4) $$ / &$r"& +!&r
#$)re+"&e3"8$ er" /e)7&e+r"&.
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 16
http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737131&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044556&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445091&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737131&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044556&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445091&version=Patient&language=Spanish7/25/2019 Expo Marcadires Tumorales (2)
17/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
Te3"7& $)$("$7& S$)8re
C4& 'e !'4 P$r$ e$(!$r ($ e@e+""7$7 /$ !e #!e7e 'er #&& e'#e,@"& #&r
e'& 7e
7/25/2019 Expo Marcadires Tumorales (2)
18/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
C$r$+er,'+"$' Se e(e$ e) e)@ere7$7e'
7/25/2019 Expo Marcadires Tumorales (2)
19/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
T"#& 7e )er )e!r&e)7&r")&' J)er "r&,+"& 7e #!(4) )e!r&e#+"$'.
GAFP: una proteina que predomina en los astrocitos y que se considera como
marcador especfico de los astrocitos en el SNC pero que tambin est presente
en las clulas de Schwann no mielinizantes del sistema nervioso perifrico. osniveles de !"#$ aumentan notablemente durante la %liosis reactiva& cuando los
astrocitos e'perimentan hipertrofia e hiperplasia
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 19
7/25/2019 Expo Marcadires Tumorales (2)
20/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
Receptores a progesterona:la positividad a los receptores a la pro%esterona
en los cnceres de mama u ovario permite asi%nar un tratamiento
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 20
7/25/2019 Expo Marcadires Tumorales (2)
21/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
Receptores estrognicos:la positividad a los receptores estro%nicos de los
cnceres de mama permite una pauta de tratamiento. (s un si%no para un buen
pron)stico
Sinaptofisina:una protena que forma parte de la membrana de las vesculas
sinpticas. (l anticuerpo obtenido del suero de cone*o reacciona con las clulas
neuroendocrinas de la mdula adrenal humana& la piel& tiroides& pulmones&
pncreas y mucosa %astrointestinal mucosa. (ste anticuerpo identifica clulas
neuroendocrinas normales y tumores neuroendocrinos
GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 21
7/25/2019 Expo Marcadires Tumorales (2)
22/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
TU*ORES SEOS =E PARTES BLAN=AS =EL SISTE*A*USCULOESMUELTICO.S4(& 'e #!e7e 7"$8)&'+"$r (& !e 'e '&'#e>$... S4(& 'e '&'#e>$ (& !e !)& &)&e &$( e)&' '$
7/25/2019 Expo Marcadires Tumorales (2)
23/23
(PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)
CONCLUSIONES
P$r$ (&' 7"@ere)+e' +"#&' 7e )er e"'+e)+e' >$/ !) $r$7&r e( !$( @$"("+$
'! )&